Tildrakizumab efficacy for psoriatic arthritis: 24-week analysis of swollen and tender joint counts and pain

被引：0
作者：
Espinoza, Luis R. [1 ]
Ballerini, Rocco [2 ]
Chou, Richard [3 ]
Rozzo, Stephen J. [4 ]
Mendelsohn, Alan M. [4 ]
机构：
[1] Louisiana State Univ, Rheumatol Sect, Hlth Sci Ctr, New Orleans, LA USA
[2] Sun Pharma Adv Res Co Ltd, Mumbai, Maharashtra, India
[3] SUNY Buffalo, Buffalo, NY USA
[4] Sun Pharma, Mumbai, Maharashtra, India
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2020年 / 83卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
15994
引用
收藏
页码：AB166 / AB166
页数：1
相关论文
共 50 条
  • [41] LONG TERM IMPROVEMENTS IN PHYSICAL FUNCTION ARE ASSOCIATED WITH IMPROVEMENTS IN DACTYLITIS, ENTHESITIS, TENDER AND SWOLLEN JOINT COUNTS, AND PSORIASIS SKIN INVOLVEMENT: RESULTS FROM A PHASE 3 STUDY OF USTEKINUMAB IN PSORIATIC ARTHRITIS PATIENTS
    Kavanaugh, A.
    Puig, L.
    Gottlieb, A. B.
    Ritchlin, C.
    Li, S.
    You, Y.
    Mendelsohn, A. M.
    Song, M.
    Rahman, P.
    McInnes, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 864 - 864
  • [42] EFFICACY AND SAFETY OF IXEKIZUMAB AT WEEK 24 IN BIOLOGIC EXPERIENCED PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS SUMMARY RESULTS
    Marzo-Ortega, Helena
    Meroni, Pierluigi
    Galindez-Agirregoikoa, Eva
    Behrens, Frank
    Bradley, Andrew J.
    Leage, Soyi Liu
    Garcia, Miriam
    Sapin, Christophe
    Ho, Ji Chen
    Constantin, Arnaud
    Hall, Stephen
    RHEUMATOLOGY, 2018, 57
  • [43] Long Term Improvements in Physical Function Are Associated with Improvements in Dactylitis, Enthesitis, Tender and Swollen Joint Counts, and Psoriasis Skin Involvement: Results from a Phase 3 Study of Ustekinumab in Psoriatic Arthritis Patients
    Kavanaugh, Arthur
    Puig Sanz, Lluis
    Gottlieb, Alice B.
    Ritchlin, Christopher T.
    Li, Shu
    You, Yin
    Mendelsohn, Alan M.
    Song, Michael
    Rahman, Proton
    McInnes, Iain B.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S688 - S688
  • [44] Long-term improvements in physical function are associated with improvements in dactylitis, enthesitis, tender and swollen joint counts, and psoriasis skin involvement: Results from a phase 3 study of ustekinumab in psoriatic arthritis patients
    Gottlieb, Alice
    Puig, Lluis
    Kavanaugh, Arthur
    Ritchlin, Christopher
    Li, Shu
    You, Yin
    Mendelsohn, Alan M.
    Song, Michael
    Rahman, Proton
    McInnes, Iain B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB239 - AB239
  • [45] Efficacy and safety of ixekizumab at week 24 in biologic-experienced patients with active psoriatic arthritis: summary results
    Marzo-Ortega, H.
    Meroni, P.
    Galindez-Agirregoikoa, E.
    Behrens, F.
    Bradley, A.
    Leage, S. Liu
    Garcia, M.
    Sapin, C.
    Ho, J.
    Constantin, A.
    Hall, S.
    Porsdal, V.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 : 43 - 44
  • [46] EFFECT OF SECUKINUMAB ON SIGNS AND SYMPTOMS OF PSORIATIC ARTHRITIS: RESULTS OF A 24-WEEK MULTICENTRE, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    McInnes, Iain
    Sieper, Joachim
    Braun, Juergen
    Emery, Paul
    van der Heijde, Desiree
    Isaacs, John
    Dahmen, Georg
    Wollenhaupt, Juergen
    Schulze-Koops, Hendrik
    Gsteiger, Sandro
    Bertolino, Arthur
    Hueber, Wolfgang
    Tak, Paul P.
    RHEUMATOLOGY, 2012, 51 : 90 - 91
  • [47] Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients With Psoriatic Arthritis: 24-Week Results of the GO-VIBRANT Trial
    Husni, M. Elaine
    Kavanaugh, Arthur
    Chan, Eric K. H.
    Peterson, Steven
    Li, Nan
    Hsia, Elizabeth C.
    Kim, Lilianne
    Lo, Kim Hung
    Harrison, Diane D.
    Han, Chenglong
    VALUE IN HEALTH, 2020, 23 (10) : 1286 - 1291
  • [48] TENIDAP VS PIROXICAM VS PIROXICAM PLUS HYDROXYCHLOROQUINE IN RHEUMATOID-ARTHRITIS - A 24-WEEK INTERIM ANALYSIS
    KRASKA, AR
    WILHELM, FE
    KIRBY, DS
    LOOSE, LD
    TING, N
    SHANAHAN, WR
    WEINER, ES
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S57 - S57
  • [49] BIMEKIZUMAB IN BDMARD-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE OPTIMAL, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED, ACTIVE REFERENCE STUDY
    McInnes, I.
    Coates, L.
    Landewe, R. B. M.
    Mease, P. J.
    Ritchlin, C. T.
    Tanaka, Y.
    Asahina, A.
    Gossec, L.
    Gottlieb, A. B.
    Warren, R. B.
    Ink, B.
    Assudani, D.
    Coarse, J.
    Bajracharya, R.
    Merola, J. F.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 206 - 207
  • [50] Higher Proportion of Rheumatoid Arthritis Patients Achieve Low Swollen and Tender Joint Counts and No Radiographic Progression with Etanercept Plus Methotrexate Versus Methotrexate Alone.
    Bananis, Eustratios
    Ferdousi, Tahmina
    Pedersen, Ronald
    Koenig, Andrew S.
    Jones, Thomas V.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S875 - S876
12345